NOTICE OF DELIVERY SERVICE DELAYS
DC Health is experiencing delays in mail availability due to the impact of COVID-19 on the US postal service.
We appreciate your patience as we continue to process all mail in as timely a manner as possible.
PROCESSING CENTER Hours:
The Health Regulation and Licensing Administration (HRLA) Processing Center is open to the public Monday, Tuesday, Thursday and Friday, 9 am – 1 pm, and Wednesday, 9 am - 3:30 pm (except holidays).
COVID-19 Guidance and Best Practices
For the most up to date information on the District's response to COVID-19, including information on best practices, licensure waivers, and recommended guidelines, please go to coronavirus.dc.gov.
Due to ongoing efforts to combat the spread of COVID-19, effective immediately, the Health Regulation and Licensing Administration (HRLA) is implementing a 100% telework policy.
Individuals may also call the Processing Center at 1 (877) 672-2174 to get an update on their pending application.
In response to the ongoing COVID-19 pandemic, all Health Professional Board meetings are currently held virtually. Please check each board's respective website for information on when the next meeting will take place.
If you are already in contact with a Health Licensing Specialist (HLS), please forward any documents to said HLS via email.
*Pharmaceutical Control Division Mailing Address Update*
EFFECTIVE IMMEDIATELY applicants must submit all facility applications to the Pharmaceutical Control Division office located at:
899 North Capitol Street, NE
Washington, DC 20002
All facility applications, with the exception of pharmacy renewals, are still paper based and must be mailed to the Pharmaceutical Control Division.
Facility applications include:
- New and renewal DM facility (Manufacturer, Distributor, Wholesaler) applications
- New and renewal controlled substance registration applications for DM facilities
- New pharmacy applications
- New controlled substance registration applications for pharmacies
- Name, location, and ownership changes for DM facilities (and their corresponding controlled substance registrations) require a new application. Upon approval, the existing license will be closed, and a new license will be issued.
In response to COVID-19, DC Health has waived all licensure requirements for practitioners who are licensed in good standing in another jurisdiction. You can read more about the waiver process HERE.
If you require assistance from the Board of Pharmacy/Pharmaceutical Control Division, please contact the following individuals by email:
Facility Licensure/Controlled Substance Registration
(Resident and Non-Resident Pharmacy, Resident and Non-Resident Drug Wholesaler, Manufacturer, and Distributor)
Ms. Sabrina Lewis
Ms. LaJuan Jeffries-Johnson
Health Practitioner Licensure/Registration
(Pharmacist, Pharmacy Intern, Pharmaceutical Detailer, Pharmacy Technician)
Ms. Karin Barron
Ms. Luanne Greenaway
(New) Health Practitioner Controlled Substance Registration
|Ms. Leatrice Lee|
(Renewal) Health Practitioner Controlled Substance Registration
Ms. Karin Barron (applicants w/ last names K-N)
Ms. Luanne Greenaway (applicants w/ last names S-V)
Ms. LaJuan Jeffries-Johnson (applicants w/ last names O-R)
Ms. Sabrina Lewis (applicants w/ last names G-J)
Ms. Leatrice Lee (applicants w/ last names A-F)
Mr. Enoh Nkeng (applicants w/ last names W-Z)
The Pharmaceutical Control Division is responsible for annual licensure inspections, surveillance, and the monitoring of activities in establishments that procure, distribute, dispense and manage prescribed/prescription products for sale or use to consumers in the District of Columbia. Regulated facilities include; pharmacies, hospitals, substance abuse treatment programs, researchers, local wholesalers, distributors, long term care facilities, animal clinics, dialysis centers and ambulatory surgical centers.
The Pharmaceutical Control Division enforces all District and federal pharmacy laws and regulations (pharmacy, controlled substances, prescription substitution, drug purity, and drug distribution and manufacturing laws and accompanying regulations, etc).
The Pharmaceutical Control Division serves as a liaison between District Government and Federal Agencies, (i.e. Food and Drug Administration, Drug Enforcement Administration, Health and Human Services, the Consumer Protection Agency, etc), involving regulatory control matters.
The Pharmaceutical Control Division conducts investigations and provides consultation to all facilities and programs that provide pharmaceutical products and services to the District of Columbia residents.
All complaints concerning the dispensing, prescribing, manufacturing, distribution, and wholesaling of drugs are investigated by Pharmaceutical Control. To file a complaint, complete the form below.
- Pharmaceutical Control Division Facility Fee Listing
- Pharmacy Licensure
- Pharmacy Licensure Renewal
- DC Controlled Substance Registration
- Drug Manufacturer, Distributor, and Wholesaler Licensure
- Continuing Education
- Hearing Aid Dealers
- Medical Marijuana Program
- Policy Statements
- Laws and Regulations [PDF]
- Remote Retail RX Demographics Report [PDF]
- Notice of Remote Controlled Substance Audit Letter [PDF]
- Pharmacy Inspection Form [PDF]
- Pharmacy Inspection Fine Schedule [PDF]
- Prescription Drug Marketing Costs - Access RX
- Complaint Process
- Yellow Fever Permits
- Prescription Drug Monitoring Program
- Prescription Fraud Reporting
- National Prescription Drug Take-Back Day
- Opioid Campaign Awareness and Education
- Managing Multiple Medications -- Age-Friendly DC Polypharmacy Pamphlet